Lakefront Biotherapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
argenx SE USD 0 0 Mar/2025
AstraZeneca USD 1.75 0.57 Jun/2026
Genmab 0 0 Mar/2025
Gilead Sciences 2.55 0.26 Jun/2026
GlaxoSmithKline 0.86 0.03 Jun/2026
GRIFOLS 3.85 1.64 Jun/2026
Hikma Pharmaceutical USD 4.02 1.1 Dec/2025
Merck 2.04 0.25 Mar/2026
Novartis USD 3.1 0.23 Jun/2026
Roche Holding 2.94 0.01 Jun/2026
Sanofi 5.49 0.51 Jun/2026
UCB 0.58 0.25 Dec/2025